Other | MassDevice

FDA okays another clinical trial for EnteroMedics anti-obesity implant

August 2, 2010 by MedCity News

EnteroMedics Inc. begins another clinical trial for its electrical shock-delivering Maestro device for treating obesity.

EnteroMedics Inc. said Monday that the Food & Drug Administration approved a new clinical trial for its Maestro anti-obesity device that uses electricity to suppress hunger.

The news represents a major victory for the Roseville, Minn.-based company, whose previous study ended in failure. Last October, initial results from the "Empower" studies of more than 400 patients showed people who used the Maestro device lost just as much weight as patients implanted with the dummy device.

Login or register to post comments
Read more

Insulet Corp. records 57% jump in 2Q revenues

July 30, 2010 by MassDevice staff

Tubeless insulin-infusion device manufacturer Insulet Corp. racks up $22.9 million in second-quarter revenues, $8.2 million higher than year-ago sales, but profits remain a distant goal

Insulet Corp. (Nasdaq:PODD) is moving into its second decade as a business looking at new markets for its OmniPod insulin infusion device, improving sales, better terms on its long-term debt and a little extra cash.

But it's still fighting a problem that's as old as the company: Net losses typically running out to eight digits.

Login or register to post comments
Read more

Celartia brings new culture incubation device to market

July 20, 2010 by MedCity News

Spanish laboratory equipment maker Celartia Ltd. launches a new cell culture incubation device in the U.S. and Canada.

By Brandon Glenn

Laboratory equipment maker Celartia Ltd. launched a new cell culture device in the U.S. and Canada.

The company said the device, called the PetakaG3, reduces cell culture contamination and is more portable than similar devices on the market, according to a statement from Celartia.

Login or register to post comments
Read more

Global Media Group

15020 North 74th Street

Scottsdale

AZ

85260

United States

(480).922.0044

www.globalmedia.com

Product(s):

Provides telemedicine hardware and software R&D, design, engineering, manufacture and support.

Investors fill MedMinder pillbox with $1.3 million prescription

April 9, 2010 by MassDevice staff

MedMinder Systems Inc. scores $1.3 million in a new equity round to promote its "smart" pill box technology.

Patients prone to forgetting when to take their medications just got a few more reminders to prod their memories — 1,265,000 more, to be exact.

MedMinder Systems Inc., a Newton, Mass.-based startup that's developing "smart" pill boxes, raised nearly $1.3 million from institutional investors in its first funding round. The proceeds are expected to be used to advance sales and marketing of Maya, the company's automated medication service.